metabolomics-the-common-denominator-@2x-768x652.png
Metabolomics: The Common Denominator to Achieve Fully Integrated, Multi-Omic Drug Development

Perhaps the most meaningful measure of a technology’s success lies in the universality of its acceptance. The completion of the Human Genome Project spawned the various ‘omics sciences nearly two decades ago. Since then, they have risen to prominence worldwide as a means for studying how genes, RNA, and proteins affect health and disease, and how they can be modified by drug treatments. ‘Omics assays are now a mainstay of drug discovery and development.

While the efficacy of genomics, transcriptomics, and proteomics for providing valuable information is irrefutable, they can be limited in their scope and utility. Download this article to discover how adding metabolomics to these other technologies can help paint a clearer picture of the phenotype.

Download Now